Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
04/2003
04/22/2003US6552065 Antiproliferative agents
04/22/2003US6552048 Sulfonylcarboxamide derivatives, process for their preparation and their use as pharmaceuticals
04/22/2003US6552028 Inhibiting the binding of eotaxin to chemokine-3 (ccr-3) receptor; antiasthmatics
04/22/2003US6552018 As antitumor agents
04/22/2003US6552013 For therapy of Alzheimer's disease
04/22/2003CA2239187C Inhibitors of farnesyl protein transferase
04/17/2003WO2003031440A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists
04/17/2003WO2003031438A1 3-[4-(substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2-indolinone derivatives as kinase inhibitors
04/17/2003WO2003031435A1 Pyrazole derivatives as glycine transporter inhibitors
04/17/2003WO2003031434A1 Compounds and methods
04/17/2003WO2003031410A1 Ligands of melanocortin receptors and compositions and methods related thereto
04/17/2003WO2003031407A2 β-LACTAMYL VASOPRESSIN VlaANTAGONISTS
04/17/2003WO2003030937A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists
04/17/2003WO2003030909A1 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
04/17/2003WO2003030902A1 Imidazole derivates as anti-inflammatory agents
04/17/2003WO2002098852A3 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins
04/17/2003WO2001094341A9 Quinazoline derivatives for the treatment of tumours
04/17/2003WO2001053275A3 Substituted aryl ketones
04/17/2003WO1999064401A3 Imidazolyl derivatives and their use as somatostatin receptor ligands
04/17/2003US20030073850 Incontinence; nasal congestion
04/17/2003US20030073849 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
04/17/2003US20030073837 Anticancer agents
04/17/2003US20030073836 Heteroarylcarboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions
04/17/2003US20030073835 Imidazolidinone derivatives
04/17/2003US20030073726 Heterocyclic inhibitors of glycine transporter 2
04/17/2003US20030073710 Compounds useful for treatment or prevention of disease mediated by alpha-2B-adrenoceptor
04/17/2003US20030073699 Compounds and methods to treat cardiac failure and other disorders
04/17/2003US20030073687 Alzheimer's disease; anticancer agents; antidiabetic agents
04/17/2003US20030073686 Anticarcinogenic agents
04/17/2003US20030073669 N-heterocyclic derivatives as NOS inhibitors
04/17/2003US20030073641 Novel N-(arylsulphonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
04/17/2003US20030073581 Spraying on plants, environment
04/17/2003US20030073047 Forms an azomethine dye upon a coupling reaction with an oxidized product of a developing agent
04/17/2003DE10135356C1 Makrocyclische Metallkomplexe und deren Verwendung zur Herstellung von Konjugaten mit Biomolekülen Macrocyclic metal complexes and their use for the preparation of conjugates with biomolecules
04/17/2003CA2462950A1 3-[4-(substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2-indolinone derivatives as kinase inhibitors
04/17/2003CA2462862A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists
04/16/2003EP1301507A2 Mannich base prodrugs of 3 - (pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
04/16/2003EP1301488A1 Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists
04/16/2003EP1301487A2 Viral polymerase inhibitors
04/16/2003EP1301484A2 Capsaicin receptor ligands
04/16/2003EP1301482A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists
04/16/2003EP1301480A1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
04/16/2003EP1301210A2 Compositions containing therapeutically active components having enhanced solubility
04/16/2003EP1015436B1 Morpholinones as light stabilizers
04/16/2003EP0880508B1 Quinazoline derivatives as vegf inhibitors
04/16/2003EP0824544B1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
04/16/2003EP0649414B1 Opioid diarylmethylpiperazines and piperidines
04/16/2003CN1411460A Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
04/16/2003CN1411457A Substituted pyrroles
04/16/2003CN1411456A Chemokine receptor binding heterocyclic compounds
04/16/2003CN1411444A Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
04/16/2003CN1411440A Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
04/16/2003CN1410835A Organic photoreceptor for electronic photographing
04/16/2003CN1410834A Organic light receptor with charge transfer compound for electronic photographing
04/16/2003CN1105716C Benzimidazole derivatives with antihistaminic activity
04/16/2003CN1105711C 嘧啶衍生物 Pyrimidine derivatives
04/16/2003CN1105709C 3-thiocarbamoylpyrazole derivatives as pesticides
04/16/2003CN1105707C Pyrazole derivative
04/16/2003CN1105706C Cyclic amidino agents useful as nitric oxide synthase inhibitors
04/15/2003US6548671 Quinoxalinyl amide derivatives
04/15/2003US6548663 Benzodiazepine vitronectin receptor antagonist pharmaceuticals
04/15/2003US6548533 Pyrrolidine carboxylic Acid or ester derivatives are useful for treating alpha 4 beta 1 mediated cell adhesion
04/15/2003US6548529 Heterocyclic containing biphenyl aP2 inhibitors and method
04/15/2003US6548525 Nitrogen containing heteroaromatics with ortho-substituted P1's as factor Xa inhibitors
04/15/2003US6548520 Substituted imidazoles having anti-cancer and cytokine inhibitory activity
04/15/2003US6548512 Nitrogen containing heteroaromatics as factor Xa inhibitors
04/15/2003US6548505 Radioprotectors
04/15/2003US6548503 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
04/15/2003US6548502 Preventing disorder selected from pathological gambling, attention deficit disorder with hyperactivity disorder, substance addiction such as drug and alcohol and sex in a mammals by administering pyrido(1,2-a) pyrazine derivatives
04/15/2003US6548499 Substituted quinoxaline derivatives as interleukin-8 receptor antagonists
04/15/2003US6548495 Dihydro-benzo [B] [1,4] diazepin-2-one derivatives
04/15/2003US6548451 Use of derivatives of 2-oxopyrrole as crop protection agents and novel 2-oxopyrroles
04/15/2003CA2190007C Antitumor indolopyrrolocarbazole derivatives
04/10/2003WO2003029359A1 Cationic reactive dyes
04/10/2003WO2003029247A1 N-heterocyclyl hydrazides as neurotrophic agents
04/10/2003WO2003029227A1 Adhesion promoters containing benzotriazoles
04/10/2003WO2003029225A1 Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them
04/10/2003WO2003029224A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003WO2003029223A1 Substituted n-(1,4,5,6-tetrahydrocyclopentapyrazol-3-yl) derivatives and the use of the same for the treatment of cancer
04/10/2003WO2003029216A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003WO2003029210A2 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
04/10/2003WO2003028729A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003WO2003028726A1 Quinoline derivatives as neuropeptide y antagonists
04/10/2003WO2003028721A2 Substituted benzimidazole compounds and their use for the treatment of cancer
04/10/2003WO2003028720A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
04/10/2003WO2003028641A2 Mch receptor antagonists
04/10/2003WO2003000186A3 Novel phenylamino-pyrimidines and uses thereof
04/10/2003WO2002102978A3 Human growth hormone antagonists
04/10/2003WO2002102793A3 Quinazolinediones as antibacterial agents
04/10/2003WO2002078639A3 A method of treating proliferative diseases using eg5 inhibitors
04/10/2003WO2002041889A3 Indolsulfonyl compounds useful in the treatment of cns disorders
04/10/2003US20030069430 Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects
04/10/2003US20030069424 Indolylmaleimide derivatives
04/10/2003US20030069299 Substituted indolinones, preparation thereof and their use as pharmaceutical compositions
04/10/2003US20030069298 Crystals including a malic acid salt of a 3-pyrrole substituted 2-indolinone, and compositions thereof
04/10/2003US20030069297 4-aryl substituted indolinones
04/10/2003US20030069292 Central nervous system disorders; anticonvulsants
04/10/2003US20030069284 Anticancer agent
04/10/2003US20030069278 Heterocyclyloxy-, -thioxy- and -aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
04/10/2003US20030069266 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives